Sanofi India Limited
961words
0turns
0analyst exchanges
0executives
Key numbers — 21 extracted
3%
ally & AI empowered capabilities To grow our legacy portfolio in CV, CNS & OAD* Domestic sales +3% YTD | Improvement in the PBT driven by the business & OPEX efficiency through • • Diabetes Fr
8 %
Net sales YTD Sep/2025 Net sales Q3/2025 ₹ in Mio Domestic Sales +3% 11.232 11.6 24 5.355 (4 8 %) 5.571 (4 8 %) +4% Export Sales - 35% 5.575 (50 %) 5.712 (4 9 %) +2% 2.738 34 1 20 25
4%
Net sales Q3/2025 ₹ in Mio Domestic Sales +3% 11.232 11.6 24 5.355 (4 8 %) 5.571 (4 8 %) +4% Export Sales - 35% 5.575 (50 %) 5.712 (4 9 %) +2% 2.738 34 1 20 25 30 2 20 24 Diab e t
35%
₹ in Mio Domestic Sales +3% 11.232 11.6 24 5.355 (4 8 %) 5.571 (4 8 %) +4% Export Sales - 35% 5.575 (50 %) 5.712 (4 9 %) +2% 2.738 34 1 20 25 30 2 20 24 Diab e t e s Insulin 20 24
50 %
estic Sales +3% 11.232 11.6 24 5.355 (4 8 %) 5.571 (4 8 %) +4% Export Sales - 35% 5.575 (50 %) 5.712 (4 9 %) +2% 2.738 34 1 20 25 30 2 20 24 Diab e t e s Insulin 20 24 20 25 Part ne
9 %
11.232 11.6 24 5.355 (4 8 %) 5.571 (4 8 %) +4% Export Sales - 35% 5.575 (50 %) 5.712 (4 9 %) +2% 2.738 34 1 20 25 30 2 20 24 Diab e t e s Insulin 20 24 20 25 Part ne rship s Ot he
2%
11.6 24 5.355 (4 8 %) 5.571 (4 8 %) +4% Export Sales - 35% 5.575 (50 %) 5.712 (4 9 %) +2% 2.738 34 1 20 25 30 2 20 24 Diab e t e s Insulin 20 24 20 25 Part ne rship s Ot he r Exp
0 %
20 24 Diab e t e s Insulin 20 24 20 25 Part ne rship s Ot he r Exp ort 1.78 6 1.78 6 (10 0 %) Domestic Sales +2% 3.9 0 1 3.9 73 1.8 22 1.9 12 +5% 1.9 19 2.0 16 16 0 20 24 4 5 20 2
5%
Ot he r Exp ort 1.78 6 1.78 6 (10 0 %) Domestic Sales +2% 3.9 0 1 3.9 73 1.8 22 1.9 12 +5% 1.9 19 2.0 16 16 0 20 24 4 5 20 25 +5% -45% Export Sales - 45% 9 8 1 54 4 20 24 20 25
45%
ic Sales +2% 3.9 0 1 3.9 73 1.8 22 1.9 12 +5% 1.9 19 2.0 16 16 0 20 24 4 5 20 25 +5% -45% Export Sales - 45% 9 8 1 54 4 20 24 20 25 Diab e t e s Insulin Part ne rship s Ot he r Ex
30%
improvement 1.253 1.267 1.443 1.468 567 538 Employees cost 695 Other OPEX 558 602 665 -30% 1.235 538 1.027 1.013 449 419 876 930 697 578 594 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2
25
%
538 1.027 1.013 449 419 876 930 697 578 594 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 % Net sales 26% 30% 30% 31% 25% 26% 22% PBT by quarter| 2024-2025 1.312 1.112 1.126 1.141